Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Dow
Teva
Daiichi Sankyo
Harvard Business School
QuintilesIMS
Citi
Federal Trade Commission
Fuji

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201150

« Back to Dashboard

NDA 201150 describes SILDENAFIL CITRATE, which is a drug marketed by Aurobindo Pharma Ltd, Actavis Grp Ptc, Amneal Pharms, Apotex Corp, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Macleods Pharms Ltd, Mylan Pharms Inc, Rubicon Res Pvt Ltd, Teva, Teva Pharms, Torrent Pharms Ltd, and Watson Labs Inc, and is included in fourteen NDAs. It is available from twenty-eight suppliers. Additional details are available on the SILDENAFIL CITRATE profile page.

The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 201150
Tradename:SILDENAFIL CITRATE
Applicant:Mylan Pharms Inc
Ingredient:sildenafil citrate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 201150
Medical Subject Heading (MeSH) Categories for 201150
Suppliers and Packaging for NDA: 201150
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 201150 ANDA Mylan Pharmaceuticals Inc. 0378-1657 N 0378-1657-77

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Nov 9, 2012TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
McKinsey
Moodys
Accenture
Mallinckrodt
Chubb
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot